Carolina Johansson

Computer Science · Physical Sciences

32h-index3.7kcitations79works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Innovative Human-Technology Interaction(11), Circadian rhythm and melatonin(10), Melanoma and MAPK Pathways(10), Interactive and Immersive Displays(6), Cutaneous Melanoma Detection and Management(5)

Publications78 total

Girl Get Dressed/Ready to Wear : Designing activities of getting dressed
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2019Open Access
Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells
Cell Death and Disease·2017· 49 citedOpen Access
Fastighetsskattens omfördelande effekter
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2017Open Access
Lower payroll taxes for young workers : Was the introduction of the payroll tax reductions for young employees an effective way to lower youth unemployment?
KTH Publication Database DiVA (KTH Royal Institute of Technology)·2016Open Access
Biotillgänglighet av atropin vid topikal ögonbehandling hos häst och metoder för objektiv mätning av tarmmotilitet
Epsilon Archive for Student Projects (University of Southampton)·2016
MGMT promoter methylation is associated with temozolomide response and prolonged progression‐free survival in disseminated cutaneous melanoma
International Journal of Cancer·2014· 52 citedOpen Access
Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance
British Journal of Cancer·2014· 43 citedOpen Access
BRAF inhibitors in cancer therapy
Pharmacology & Therapeutics·2013· 113 cited
KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma
Journal of Dermatological Science·2013· 93 cited
Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines
Melanoma Research·2013· 24 cited
Somatic BRAF and NRAS Mutations in Familial Melanomas with Known Germline CDKN2A Status: A GenoMEL Study
Journal of Investigative Dermatology·2013· 20 cited
The design space of body games
2013· 110 cited
Seeing movement qualities
2013· 41 cited
140 Unraveling BRAF Inhibitor (PLX4032) Resistance Mechanisms
European Journal of Cancer·2012
Therapeutics
Annals of Oncology·2012· 2 cited
P2.17 Proteomics and Gene Expression Profiling of Melanoma Chemotherapy Response in Tumors
Annals of Oncology·2012· 3 citedOpen Access
P2.04 Effects of Combined Exposure To Braf and Pi3K Inhibitors With Chemotherapeutic Agents
Annals of Oncology·2012
<i>KIT</i>, <i>NRAS</i>, <i>BRAF</i>, and <i>PTEN</i> alterations in acral lentiginous melanomas.
Journal of Clinical Oncology·2012· 1 cited
Body, movement, gesture &amp; tactility in interaction with mobile devices
2011· 3 cited
Abstract 3495: Targeted therapies in melanoma – in vitro effects of single and combined drug treatment
Cancer Research·2011
page 1 of 4Next →

Frequent Co-authors

Martin Schalling(10), Sandra Ceccatelli(9), Marianne Frostvik Stolt(7), Rolf Adolfsson(6), Timo Partonen(6), Suzanne Egyházi Brage(6), Tiina Paunio(5), Jeanette E. Johansen(4), Christina Smedh(4), Siegfried Kasper(4), Jakob Tholander(4), Johan Hansson(4), Alireza Azimi(4), Christian Broberger(3), Tomas Hökfelt(3), Matthäus Willeit(3), Jenny Ekholm(3), Tuula Kieseppä(3), Dirk Lichtermann(3), N. Praschak-Rieder(3)